Evaluation of Rifamycin SV and Rifampin Kinetics in Lactating Ewes
- 1 February 1974
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 5 (2) , 139-142
- https://doi.org/10.1128/aac.5.2.139
Abstract
Serum and milk concentrations of rifamycin SV and rifampin were determined in lactating ewes after a single intravenous injection, and pharmacokinetic parameters were evaluated by the two-compartment open-system model. Rifampin was distributed throughout a greater volume than rifamycin SV and was eliminated more slowly from the body. The concentrations of the two drugs, both lipophilic weak acids, in milk after intravenous or intramuscular injection were lower than in serum, but rifampin was detected in milk sooner and for longer periods than rifamycin SV. Under constant serum drug concentrations, the observed milk/serum ultrafiltrate concentrations ratios (0.19 to 0.29 for rifamycin SV, and 0.90 to 1.28 for rifampin) were close to the calculated ratios derived from the pH-pK passive diffusion concept.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetic evaluation of penicillin and cephalosporin derivatives in serum and milk of lactating cows and ewes.1973
- Binding of Antibiotics to Bovine and Ovine SerumAntimicrobial Agents and Chemotherapy, 1972
- The use of rifamycin SV in the treatment of bovine mastitisPublished by Wiley ,1971
- Effect of Mode of Administration on Drug Distribution in a Two-Compartment Open SystemJournal of Pharmaceutical Sciences, 1969
- Concept of a Volume of Distribution and Possible Errors in Evaluation of This ParameterJournal of Pharmaceutical Sciences, 1968
- Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single CompartmentJournal of Pharmaceutical Sciences, 1968
- Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.1967
- Estimation of Volume of Distribution and Half-Life of a Compound After Rapid Intravenous InjectionJournal of Pharmaceutical Sciences, 1967
- Rifampicin: A New Orally Active RifamycinChemotherapy, 1966
- Rifamycin SV. A review.1965